Viemed Healthcare (VMD) Net Cash Flow (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Viemed Healthcare | 373.53 Mn | 365.70 Mn | 42.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -257.23% |
| Dec 31, 2025 | 126.74% |
| Sep 30, 2025 | -190.23% |
| Jun 30, 2025 | 233.55% |
| Mar 31, 2025 | -219.17% |
| Dec 31, 2024 | 143.82% |
| Sep 30, 2024 | 69.56% |
| Jun 30, 2024 | 127.09% |
| Mar 31, 2024 | -300.29% |
| Dec 31, 2023 | 1,991.10% |
| Sep 30, 2023 | 98.90% |
| Jun 30, 2023 | -300.90% |
| Mar 31, 2023 | 245.27% |
| Dec 31, 2022 | -927.93% |
| Sep 30, 2022 | 93.94% |
| Jun 30, 2022 | -972.14% |
| Mar 31, 2022 | -45.49% |
| Dec 31, 2021 | 135.97% |
| Sep 30, 2021 | -8,033.33% |
| Jun 30, 2021 | -53.45% |
| Mar 31, 2021 | 108.20% |
| Dec 31, 2020 | -152.62% |
| Sep 30, 2020 | -87.37% |
| Jun 30, 2020 | 530.61% |
| Mar 31, 2020 | -782.21% |
| Dec 31, 2019 | -85.32% |
| Sep 30, 2019 | 1,657.65% |
| Jun 30, 2019 | 109.36% |
| Mar 31, 2019 | -1,356.49% |
| Dec 31, 2018 | -85.27% |